EpiPen's price has ballooned about 400% since 2008, rising from about a $100 list price to $500 today. The EpiPen is one of the most important life-saving medical innovations for people with severe food allergies—which affect as many as 15 million Americans and 1 in 13 children in the United States. But its price has exploded over the last decade despite few upgrades to the product itself. The product's lack of competitors is likely a significant driver of the costs. [...] [The] EpiPen enjoys a near-monopoly on the market with annual sales of more than $1.3 billion and nearly 90% U.S. market share.
(Score: 3, Insightful) by jelizondo on Tuesday August 23 2016, @11:55PM
Oh, my god.
You mean as long as it is profitable it is free enterprise and we hate the government; as soon as large loses loom, flip-flop, we love the government and please bail us out.
Please stop watching Fox News, their universe is completely different from the one you and I live in.
(Score: 0, Troll) by khallow on Wednesday August 24 2016, @12:20AM
You mean as long as it is profitable it is free enterprise and we hate the government; as soon as large loses loom, flip-flop, we love the government and please bail us out.
You know, you could think. So let's try that. What is the research that is so expensive and so risky, yet still has a huge return on investment to justify public funding rather than private? Sorry, it doesn't exist. Even stuff like space stations or large particle colliders are within the grasp of the private world. Instead, we see the usual squandering of public funds on scientific white elephants, and people with a remarkable willful ignorance of economics.